Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
2021
2020
Americas
Clear all
Type of publications
NITAG documentation
(123)
Systematic reviews (SYSVAC)
(3)
Topics
Available to download in languages
Regions
Americas
(126)
Africa
(18)
Europe
(93)
South-East Asia
(3)
Western Pacific
(33)
Countries
Argentina
(1)
Bolivia
(2)
Canada
(20)
Chile
(18)
United States of America
(85)
Diseases
COVID-19
(126)
Diphtheria
(1)
Ebola
(1)
Hepatitis A
(1)
Human papillomavirus (HPV)
(7)
Influenza
(4)
Meningococcal disease
(2)
Pertussis
(1)
Pneumococcal disease
(1)
Rotavirus
(2)
Tetanus
(1)
Vaccine topics
Acceptance
(1)
Coverage
(1)
Ethical issues
(2)
Target population
Adults
(2)
All age groups
(2)
Children
(3)
Healthcare workers
(3)
Older adults
(2)
Parents/caregivers
(1)
Pregnant women
(4)
Risk group
(3)
Publication date
2021
(64)
2020
(62)
2024
(1)
2023
(10)
2022
(40)
2018
(2)
2010
(1)
2001
(1)
126 results found
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine
2021
∙
ACIP
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update of ACIP - 9 July 2021
2020
∙
CAVEI
CAVEI recommendation to prioritize vaccination against SARS-COV-2 in people over 65 years in the context of limited supply of vaccines
2020
∙
Melinda Wharton, ACIP
ACIP COVID-19 Vaccine Safety Technical Sub-Group
2020
∙
Beth Bell, ACIP
ACIP COVID-19 Vaccines Work Group - overview of American vaccines in development
2020
∙
Thomas Clark, ACIP
Anaphylaxis Following m-RNA COVID-19 Vaccine Receipt
2020
∙
William Gruber, ACIP
BNT162b2 Vaccine Candidate Against COVID-19
2020
∙
CAVEI
CAVEI interim recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register